- Report
- February 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- February 2025
- 150 Pages
Global
From €4424EUR$4,850USD£3,782GBP
- Report
- October 2024
- 136 Pages
North America
From €3649EUR$4,000USD£3,119GBP
- Report
- August 2022
- 120 Pages
Global
From €4105EUR$4,500USD£3,509GBP
- Report
- February 2024
- 182 Pages
Global
From €4105EUR$4,500USD£3,509GBP
- Report
- April 2025
- 50 Pages
Global
From €2417EUR$2,650USD£2,066GBP
Moexipril is a cardiovascular drug used to treat hypertension and congestive heart failure. It is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the production of a hormone that causes blood vessels to narrow. This helps to reduce blood pressure and improve the flow of blood and oxygen to the heart. Moexipril is usually taken once a day, and is available in both generic and brand-name forms. Common side effects include dizziness, headache, and fatigue.
Moexipril is a widely used drug in the cardiovascular market, and is prescribed by doctors to treat a variety of conditions. It is often used in combination with other medications, such as diuretics, to help control blood pressure. It is also used to reduce the risk of stroke and heart attack in people with high blood pressure.
The market for Moexipril is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the companies in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more